Inhibitors of HIV-1 Tat-Mediated Transactivation

$63.10 plus tax (Refund Policy)

Buy Article:

Abstract:

The transactivation responsive (TAR) RNA is the 5'-leader sequence of the HIV-1 mRNA genome and interacts with the Tat protein during transcription. Tat and the positive transcription elongation factor (PTEFb) complex bind to TAR to promote efficient transcription of the full-length HIV genome. In the absence of the TAR█Tat█P-TEFb interaction, viral transcription is inefficient, which makes this RNA-protein complex an important target for therapeutic intervention of HIV replication. Inhibitors of HIV-1 transactivation mainly target: 1) TAR RNA, 2) Tat protein and 3) Tat█P-TEFb complex. 1) Compounds against TAR RNA are the most numerous: besides cationic peptides, which were initially developed, recent advances in TAR binding inhibitors include oligonucleotide based-agents and small molecules. Specific research efforts are currently underway to increase cellular uptake. 2) By targeting the Tat protein, both transactivation and other Tatmediated intra/extracellular functions are affected. Various biopolymeric drugs are reported to effectively inhibit Tat activity. In addition, Tat-targeted antibodies have recently been developed. 3) Intracellular proteins have been discovered to disrupt Tat█P-TEFb interaction, raising the chance of inhibiting HIV-1 transcription via novel mechanisms.

Keywords: HIV-1; Inhibitors; P-TEFb; TAR RNA; Tat; Transactivation

Document Type: Research Article

DOI: http://dx.doi.org/10.2174/092986706776872989

Affiliations: Department of Histology, Microbiology and Medicinal Biotechnologies, University of Padova, via Gabelli 63, 35123 Padova, Italy.

Publication date: May 1, 2006

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more